title: When Life Expectancy is Not Short Enough: A Perspective on the National Institute for Health and Care Excellence (NICE) Preliminary Guidance for Dinutuximab.
authors.affiliation: Children's Oncology Group, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Adamson
authors.affiliation: Division of Pediatric Hematology and Oncology, Seattle Children's Hospital/University of Washington, Seattle, Washington.
authors.forename: Julie R
authors.initials: JR
authors.lastname: Park
authors.affiliation: Formerly, Division of Clinical Studies, The Institute of Cancer Research, London, UK.|Formerly, Paediatric Drug Development, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Pearson
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D017277:Drug Approval / Q000331:legislation & jurisprudence; D006801:Humans; D008017:Life Expectancy; D009447:Neuroblastoma / Q000188:drug therapy*; D006113:United Kingdom
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C112746:dinutuximab